Skip to main content

Pfizer balance sheet

  • PFE · NYSE
  • Pharmaceuticals
  • S&P 500
$28.89+0.21%Close 13 Nov 2026 · Market value $164.8B

At the end of fiscal 2025 (the year to 31 Dec 2025), Pfizer reported total assets of $208.2B, $1.14B in cash and equivalents, $67.42B of total debt; shareholders' equity was $86.48B.

From Pfizer's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Pfizer balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$3.41B$2.12B$1.98B$1.74B$3.18B$10.08B$2.18B$3.34B$3.64B$2.60B$1.34B$1.14B$1.12B$1.79B$1.94B$416.0M$2.85B$1.04B$1.14B
Short-term investments—$21.61B$23.99B$26.28B$23.27B$22.32B$30.23B$32.78B$19.65B$15.26B$18.65B$17.69B$8.53B$10.44B$29.13B$22.32B$9.84B$19.43B$12.45B
Cash and short-term investments$3.41B$23.73B$25.97B$28.01B$26.45B$32.40B$32.41B$36.12B$23.29B$17.85B$19.99B$18.83B$9.65B$12.22B$31.07B$22.73B$12.69B$20.48B$13.60B
Accounts receivable—$8.96B$14.64B$13.38B$13.06B$10.68B$9.36B$8.40B$8.18B$8.22B$8.22B$8.03B$6.77B$7.91B$11.48B$10.95B$11.57B$11.46B$11.87B
Inventory—$4.38B$12.40B$8.28B$6.61B$6.08B$6.17B$5.66B$7.51B$6.78B$7.58B$7.51B$7.07B$8.02B$9.06B$8.98B$10.19B$10.85B$10.65B
Current assets—$43.08B$61.67B$61.01B$60.82B$64.83B$56.24B$55.59B$43.80B$38.95B$41.14B$49.93B$32.80B$35.07B$59.69B$51.26B$43.33B$50.36B$42.90B
Property, plant and equipment—$13.29B$22.78B$18.64B$15.92B$13.21B$12.40B$11.76B$13.77B$13.32B$13.87B$13.38B$12.97B$13.74B$14.88B$16.27B$18.94B$18.39B$19.32B
Goodwill—$21.46B$42.38B$43.93B$44.57B$43.66B$42.52B$42.07B$48.24B$54.45B$55.95B$53.41B$48.20B$49.56B$49.21B$51.38B$67.78B$68.53B$71.26B
Acquired intangibles—$17.72B$68.02B$57.55B$51.18B$45.15B$39.38B$35.17B$40.36B$52.65B$48.74B$35.21B$33.94B$28.34B$25.15B$43.37B$64.90B$55.41B$53.73B
Long-term investments————$9.81B$14.15B$16.41B$17.52B$16.00B$7.12B$7.01B$2.59B$20.15B$20.26B$21.53B$15.07B$15.37B$2.23B—
Total assets—$111.1B$212.9B$195.0B$188.0B$185.8B$172.1B$167.6B$167.4B$171.6B$171.8B$159.4B$167.6B$154.2B$181.5B$197.2B$226.5B$213.4B$208.2B
Accounts payable—$1.75B$4.37B$3.99B$3.68B$2.92B$3.23B$3.21B$3.62B$4.54B$4.66B$4.67B$3.89B$4.28B$5.58B$6.81B$6.71B$5.63B$5.24B
Unearned revenue, current—————————————$1.11B$3.07B$2.52B$2.70B$1.51B$784.0M
Short-term borrowings—————$2.70B$3.00B——$673.0M$320.0M$966.0M$860.0M$145.0M$605.0M$385.0M$252.0M$755.0M$157.0M
Long-term debt · current portion—$937.0M$27.00M$3.50B$6.00M$2.45B$2.06B$3.01B$3.72B$4.22B$3.55B$4.78B$1.46B$2.00B$1.64B$2.56B$2.25B$3.75B$3.00B
Current liabilities—$27.01B$37.23B$28.64B$28.91B$29.19B$23.37B$21.59B$29.40B$31.11B$30.43B$31.86B$37.30B$25.92B$42.67B$42.14B$47.79B$42.99B$36.98B
Long-term debt · non-current—$7.96B$43.19B$38.41B$34.93B$31.04B$30.46B$31.54B$28.74B$31.40B$33.54B$32.91B$35.95B$37.13B$36.20B$32.88B$61.54B$57.41B$61.64B
Operating lease liability————————————$1.32B$1.44B$2.96B$3.22B$3.15B$2.64B$2.62B
Total liabilities—$53.41B$122.5B$106.7B$105.4B$104.1B$95.48B$95.94B$102.4B$111.8B$100.1B$95.66B$104.1B$90.76B$104.0B$101.3B$137.2B$124.9B$121.4B
Retained earnings—$49.14B$40.43B$42.72B$46.21B$54.24B$69.73B$72.18B$71.99B$71.77B$85.29B$89.55B$97.67B$90.39B$103.4B$125.7B$118.4B$116.7B$114.6B
Minority interest—$184.0M$432.0M$452.0M$431.0M$418.0M$313.0M$321.0M$278.0M$296.0M$348.0M$351.0M$303.0M$235.0M$262.0M$256.0M$274.0M$294.0M$299.0M
Shareholders' equity$65.12B$57.56B$90.01B$87.81B$82.19B$81.26B$76.31B$71.30B$64.72B$59.54B$71.31B$63.41B$63.14B$63.24B$77.20B$95.66B$89.01B$88.20B$86.48B
Total liabilities and equity—$111.1B$212.9B$195.0B$188.0B$185.8B$172.1B$167.6B$167.4B$171.6B$171.8B$159.4B$167.6B$154.2B$181.5B$197.2B$226.5B$213.4B$208.2B
Total debt—$8.90B$43.22B$41.91B$34.93B$36.19B$35.52B$34.55B$32.46B$36.30B$37.40B$38.65B$39.60B$40.72B$41.40B$39.05B$67.20B$64.55B$67.42B
Net debt—−$14.83B$17.25B$13.90B$8.48B$3.79B$3.11B−$1.57B$9.17B$18.45B$17.41B$19.82B$29.95B$28.49B$10.33B$16.31B$54.51B$44.07B$53.82B
Net working capital—$13.95B$22.47B$30.64B$28.73B$25.56B$30.70B$30.66B$10.76B$5.24B$9.37B$16.93B−$5.62B$7.36B$15.08B$8.71B−$7.31B$6.32B$4.77B
Shares outstanding · period end——8.1B8.0B7.5B7.2B6.4B6.1B6.2B6.0B6.0B5.6B5.5B5.6B5.6B5.6B5.6B5.7B5.7B

Quarterly

Pfizer balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$2.85B$719.0M$1.05B$1.09B$1.04B$1.43B$1.64B$1.34B$1.14B$1.70B$976.0M$1.82B
Short-term investments$9.84B$11.21B$6.05B$8.86B$19.43B$15.89B$11.61B$13.64B$12.45B$11.37B$10.72B$12.45B
Cash and short-term investments$12.69B$11.93B$7.10B$9.95B$20.48B$17.32B$13.25B$14.98B$13.60B$13.07B$11.70B$14.27B
Accounts receivable$11.57B$10.99B$11.39B$14.45B$11.46B$11.85B$12.08B$14.26B$11.87B$12.59B$12.49B$14.19B
Inventory$10.19B$10.89B$11.45B$11.72B$10.85B$10.85B$11.67B$11.47B$10.65B$10.67B$9.95B$10.02B
Current assets$43.33B$42.41B$37.83B$43.22B$50.36B$45.86B$43.70B$46.92B$42.90B$42.82B$41.36B$45.01B
Property, plant and equipment$18.94B$18.80B$18.96B$18.54B$18.39B$18.35B$18.78B$18.88B$19.32B$19.40B$19.03B$19.05B
Goodwill$67.78B$69.30B$68.44B$68.57B$68.53B$68.44B$69.00B$69.10B$71.26B$71.41B$71.42B$71.46B
Acquired intangibles$64.90B$62.83B$61.24B$59.99B$55.41B$53.98B$52.70B$51.32B$53.73B$52.56B$47.05B$45.96B
Long-term investments$15.37B$11.61B$11.15B$10.76B$2.23B$2.01B$2.12B—————
Total assets$226.5B$221.1B$216.2B$219.5B$213.4B$208.0B$206.1B$208.7B$208.2B$207.6B$201.1B$204.5B
Accounts payable$6.71B$5.59B$5.11B$5.31B$5.63B$5.24B$5.17B$5.02B$5.24B$4.51B$4.58B$4.07B
Unearned revenue, current$2.70B$2.50B$2.53B$2.02B$1.51B$1.01B$1.12B$924.0M$784.0M———
Short-term borrowings$252.0M$362.0M$320.0M$160.0M$755.0M$567.0M$50.00M$56.00M$157.0M$29.00M$94.00M$70.00M
Long-term debt · current portion$2.25B$1.00B$3.75B$3.75B$3.75B$3.75B$4.25B$4.25B$3.00B$3.86B$2.60B$2.60B
Current liabilities$47.79B$40.50B$43.82B$43.21B$42.99B$36.45B$37.73B$36.60B$36.98B$34.35B$32.65B$31.73B
Long-term debt · non-current$61.54B$61.31B$57.51B$58.00B$57.41B$57.64B$57.50B$57.41B$61.64B$60.56B$60.49B$60.00B
Operating lease liability$3.15B———$2.64B———$2.62B———
Total liabilities$137.2B$128.5B$128.2B$126.9B$124.9B$117.4B$117.1B$115.6B$121.4B$117.2B$115.6B$115.2B
Retained earnings$118.4B$121.3B$116.6B$121.1B$116.7B$119.6B$117.6B$121.2B$114.6B$117.2B$112.1B$115.3B
Minority interest$274.0M$276.0M$275.0M$272.0M$294.0M$299.0M$317.0M$295.0M$299.0M$303.0M$302.0M$299.0M
Shareholders' equity$89.01B$92.28B$87.70B$92.29B$88.20B$90.34B$88.69B$92.80B$86.48B$90.10B$85.19B$89.00B
Total liabilities and equity$226.5B$221.1B$216.2B$219.5B$213.4B$208.0B$206.1B$208.7B$208.2B$207.6B$201.1B$204.5B
Total debt$67.20B$62.67B$61.57B$61.91B$64.55B$61.95B$61.80B$61.71B$67.42B$64.45B$63.19B$62.67B
Net debt$54.51B$50.74B$54.47B$51.96B$44.07B$44.64B$48.55B$46.73B$53.82B$51.38B$51.49B$48.40B
Net working capital−$7.31B$1.20B−$7.05B−$1.08B$6.32B$7.98B$4.34B$8.98B$4.77B$6.77B$7.74B$11.46B
Shares outstanding · period end5.6B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B5.7B

The main figures as JSON and plain text. See data and methodology.

PFE in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.